4-butyrolactone has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cios, A; Filipek, B; Malawska, B; Mogilski, S; Sałat, K; Sałat, R; Więckowski, K; Wyska, E | 1 |
| Filipek, B; Malawska, B; Nowak, B; Sałat, K; Sołtys, Z; Więckowski, K; Witalis, J; Zadrożna, M | 1 |
2 other study(ies) available for 4-butyrolactone and Neuralgia
| Article | Year |
|---|---|
Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice.
Topics: 4-Butyrolactone; Analgesics; Animals; Antineoplastic Agents; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Male; Mice; Neuralgia; Pain Measurement; Piperazines; Pregabalin; Touch | 2014 |
3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury.
Topics: 4-Butyrolactone; Analgesics; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Hot Temperature; Hyperalgesia; Male; Mice; Nerve Growth Factor; Neuralgia; Pain Measurement; Physical Stimulation; Piperazines; Postural Balance; Pregabalin; Sciatic Nerve | 2015 |